Alpha cognition inc. announces proposed public offering of common shares

Vancouver, british columbia & dallas--(business wire)--alpha cognition inc. (nasdaq: acog) (the “company”), a commercial-stage biopharmaceutical company dedicated to developing innovative treatments for neurodegenerative diseases, today announced that it is proposing to offer and sell its common shares and, in lieu of common shares to certain investors, pre-funded warrants to purchase its common shares, in an underwritten public offering. in addition, the company intends to grant the underwrite.
ACOG Ratings Summary
ACOG Quant Ranking